Capacity for the management of kidney failure in the International Society of Nephrology Middle East region : report from the 2023 ISN Global Kidney Health Atlas (ISN-GKHA)
© 2024 International Society of Nephrology. Published by Elsevier Inc. All rights reserved..
The highest financial and symptom burdens and the lowest health-related quality-of-life scores are seen in people with kidney failure. A total of 11 countries in the International Society of Nephrology (ISN) Middle East region responded to the ISN-Global Kidney Health Atlas. The prevalence of chronic kidney disease (CKD) in the region ranged from 4.9% in Yemen to 12.2% in Lebanon, whereas prevalence of kidney failure treated with dialysis or transplantation ranged from 152 per million population (pmp) in the United Arab Emirates to 869 pmp in Kuwait. Overall, the incidence of kidney transplantation was highest in Saudi Arabia (20.2 pmp) and was lowest in Oman (2.2 pmp). Chronic hemodialysis (HD) and peritoneal dialysis (PD) services were available in all countries, whereas kidney transplantation was available in most countries of the region. Public government funding that makes acute dialysis, chronic HD, chronic PD, and kidney transplantation medications free at the point of delivery was available in 54.5%, 72.7%, 54.5%, and 54.5% of countries, respectively. Conservative kidney management was available in 45% of countries. Only Oman had a CKD registry; 7 countries (64%) had dialysis registries, and 8 (73%) had kidney transplantation registries. The ISN Middle East region has a high burden of kidney disease and multiple challenges to overcome. Prevention and detection of kidney disease can be improved by the design of tailored guidelines, allocation of additional resources, improvement of early detection at all levels of care, and implementation of sustainable health information systems.
| Errataetall: |
CommentIn: Kidney Int Suppl (2011). 2024 Apr;13(1):1-5. - PMID 38619132 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:13 |
|---|---|
| Enthalten in: |
Kidney international supplements - 13(2024), 1 vom: 04. Apr., Seite 57-70 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Karam, Sabine [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Epidemiology |
|---|
| Anmerkungen: |
Date Revised 25.04.2024 published: Print-Electronic CommentIn: Kidney Int Suppl (2011). 2024 Apr;13(1):1-5. - PMID 38619132 Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1016/j.kisu.2024.01.009 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM371078261 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM371078261 | ||
| 003 | DE-627 | ||
| 005 | 20240425234652.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240415s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.kisu.2024.01.009 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1386.xml |
| 035 | |a (DE-627)NLM371078261 | ||
| 035 | |a (NLM)38618498 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Karam, Sabine |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Capacity for the management of kidney failure in the International Society of Nephrology Middle East region |b report from the 2023 ISN Global Kidney Health Atlas (ISN-GKHA) |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 25.04.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentIn: Kidney Int Suppl (2011). 2024 Apr;13(1):1-5. - PMID 38619132 | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a © 2024 International Society of Nephrology. Published by Elsevier Inc. All rights reserved. | ||
| 520 | |a The highest financial and symptom burdens and the lowest health-related quality-of-life scores are seen in people with kidney failure. A total of 11 countries in the International Society of Nephrology (ISN) Middle East region responded to the ISN-Global Kidney Health Atlas. The prevalence of chronic kidney disease (CKD) in the region ranged from 4.9% in Yemen to 12.2% in Lebanon, whereas prevalence of kidney failure treated with dialysis or transplantation ranged from 152 per million population (pmp) in the United Arab Emirates to 869 pmp in Kuwait. Overall, the incidence of kidney transplantation was highest in Saudi Arabia (20.2 pmp) and was lowest in Oman (2.2 pmp). Chronic hemodialysis (HD) and peritoneal dialysis (PD) services were available in all countries, whereas kidney transplantation was available in most countries of the region. Public government funding that makes acute dialysis, chronic HD, chronic PD, and kidney transplantation medications free at the point of delivery was available in 54.5%, 72.7%, 54.5%, and 54.5% of countries, respectively. Conservative kidney management was available in 45% of countries. Only Oman had a CKD registry; 7 countries (64%) had dialysis registries, and 8 (73%) had kidney transplantation registries. The ISN Middle East region has a high burden of kidney disease and multiple challenges to overcome. Prevention and detection of kidney disease can be improved by the design of tailored guidelines, allocation of additional resources, improvement of early detection at all levels of care, and implementation of sustainable health information systems | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Global Kidney Health Atlas | |
| 650 | 4 | |a ISN | |
| 650 | 4 | |a epidemiology | |
| 650 | 4 | |a kidney failure | |
| 650 | 4 | |a kidney replacement therapy | |
| 650 | 4 | |a the Middle East | |
| 700 | 1 | |a Amouzegar, Atefeh |e verfasserin |4 aut | |
| 700 | 1 | |a Alshamsi, Iman Rashed |e verfasserin |4 aut | |
| 700 | 1 | |a Al Ghamdi, Saeed M G |e verfasserin |4 aut | |
| 700 | 1 | |a Anwar, Siddiq |e verfasserin |4 aut | |
| 700 | 1 | |a Ghnaimat, Mohammad |e verfasserin |4 aut | |
| 700 | 1 | |a Saeed, Bassam |e verfasserin |4 aut | |
| 700 | 1 | |a Arruebo, Silvia |e verfasserin |4 aut | |
| 700 | 1 | |a Bello, Aminu K |e verfasserin |4 aut | |
| 700 | 1 | |a Caskey, Fergus J |e verfasserin |4 aut | |
| 700 | 1 | |a Damster, Sandrine |e verfasserin |4 aut | |
| 700 | 1 | |a Donner, Jo-Ann |e verfasserin |4 aut | |
| 700 | 1 | |a Jha, Vivekanand |e verfasserin |4 aut | |
| 700 | 1 | |a Johnson, David W |e verfasserin |4 aut | |
| 700 | 1 | |a Levin, Adeera |e verfasserin |4 aut | |
| 700 | 1 | |a Malik, Charu |e verfasserin |4 aut | |
| 700 | 1 | |a Nangaku, Masaomi |e verfasserin |4 aut | |
| 700 | 1 | |a Okpechi, Ikechi G |e verfasserin |4 aut | |
| 700 | 1 | |a Tonelli, Marcello |e verfasserin |4 aut | |
| 700 | 1 | |a Ye, Feng |e verfasserin |4 aut | |
| 700 | 1 | |a Abu-Alfa, Ali K |e verfasserin |4 aut | |
| 700 | 1 | |a Savaj, Shokoufeh |e verfasserin |4 aut | |
| 700 | 0 | |a Regional Board and ISN-GKHA Team Authors |e verfasserin |4 aut | |
| 700 | 1 | |a Abou-Jaoudeh, Pauline |e investigator |4 oth | |
| 700 | 1 | |a Al Hussain, Turki |e investigator |4 oth | |
| 700 | 1 | |a Al Salmi, Issa Salim Amur |e investigator |4 oth | |
| 700 | 1 | |a Alrukhaimi, Mona |e investigator |4 oth | |
| 700 | 1 | |a Alyousef, Anas |e investigator |4 oth | |
| 700 | 1 | |a Bahous, Sola Aoun |e investigator |4 oth | |
| 700 | 1 | |a Cai, Guangyan |e investigator |4 oth | |
| 700 | 1 | |a Cheikh Hassan, Hicham I |e investigator |4 oth | |
| 700 | 1 | |a Cho, Yeoungjee |e investigator |4 oth | |
| 700 | 1 | |a Davids, M Razeen |e investigator |4 oth | |
| 700 | 1 | |a Davison, Sara N |e investigator |4 oth | |
| 700 | 1 | |a Diongole, Hassane M |e investigator |4 oth | |
| 700 | 1 | |a Divyaveer, Smita |e investigator |4 oth | |
| 700 | 1 | |a Ekrikpo, Udeme E |e investigator |4 oth | |
| 700 | 1 | |a Ethier, Isabelle |e investigator |4 oth | |
| 700 | 1 | |a Fung, Winston Wing-Shing |e investigator |4 oth | |
| 700 | 1 | |a Ghimire, Anukul |e investigator |4 oth | |
| 700 | 1 | |a Hooman, Nakysa |e investigator |4 oth | |
| 700 | 1 | |a Houston, Ghenette |e investigator |4 oth | |
| 700 | 1 | |a Htay, Htay |e investigator |4 oth | |
| 700 | 1 | |a Ibrahim, Kwaifa Salihu |e investigator |4 oth | |
| 700 | 1 | |a Irish, Georgina |e investigator |4 oth | |
| 700 | 1 | |a Jindal, Kailash |e investigator |4 oth | |
| 700 | 1 | |a Kelly, Dearbhla M |e investigator |4 oth | |
| 700 | 1 | |a Lalji, Rowena |e investigator |4 oth | |
| 700 | 1 | |a Mitwali, Ahmed |e investigator |4 oth | |
| 700 | 1 | |a Mortazavi, Mojgan |e investigator |4 oth | |
| 700 | 1 | |a Nalado, Aisha M |e investigator |4 oth | |
| 700 | 1 | |a Neuen, Brendon L |e investigator |4 oth | |
| 700 | 1 | |a Olanrewaju, Timothy O |e investigator |4 oth | |
| 700 | 1 | |a Osman, Mohamed A |e investigator |4 oth | |
| 700 | 1 | |a Ossareh, Shahrzad |e investigator |4 oth | |
| 700 | 1 | |a Petrova, Anna |e investigator |4 oth | |
| 700 | 1 | |a Riaz, Parnian |e investigator |4 oth | |
| 700 | 1 | |a Saad, Syed |e investigator |4 oth | |
| 700 | 1 | |a Sakajiki, Aminu Muhammad |e investigator |4 oth | |
| 700 | 1 | |a See, Emily |e investigator |4 oth | |
| 700 | 1 | |a Sozio, Stephen M |e investigator |4 oth | |
| 700 | 1 | |a Tiv, Sophanny |e investigator |4 oth | |
| 700 | 1 | |a Tungsanga, Somkanya |e investigator |4 oth | |
| 700 | 1 | |a Viecelli, Andrea |e investigator |4 oth | |
| 700 | 1 | |a Wainstein, Marina |e investigator |4 oth | |
| 700 | 1 | |a Wannous, Hala |e investigator |4 oth | |
| 700 | 1 | |a Yeung, Emily K |e investigator |4 oth | |
| 700 | 1 | |a Zaidi, Deenaz |e investigator |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Kidney international supplements |d 2011 |g 13(2024), 1 vom: 04. Apr., Seite 57-70 |w (DE-627)NLM240029828 |x 2157-1724 |7 nnns |
| 773 | 1 | 8 | |g volume:13 |g year:2024 |g number:1 |g day:04 |g month:04 |g pages:57-70 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.kisu.2024.01.009 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 13 |j 2024 |e 1 |b 04 |c 04 |h 57-70 | ||